Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AZN |
---|---|---|
09:32 ET | 117064 | 64.89 |
09:34 ET | 49192 | 64.93 |
09:36 ET | 59170 | 65 |
09:38 ET | 73273 | 64.87 |
09:39 ET | 37757 | 65.05 |
09:41 ET | 39870 | 65.02 |
09:43 ET | 32068 | 65.09 |
09:45 ET | 43796 | 65.25 |
09:48 ET | 42206 | 65.24 |
09:50 ET | 37019 | 65.3 |
09:52 ET | 54316 | 65.29 |
09:54 ET | 79128 | 65.25 |
09:56 ET | 44322 | 65.22 |
09:57 ET | 26318 | 65.26 |
09:59 ET | 38022 | 65.27 |
10:01 ET | 23548 | 65.29 |
10:03 ET | 16127 | 65.09 |
10:06 ET | 25318 | 65.01 |
10:08 ET | 44365 | 65.13 |
10:10 ET | 57373 | 65.22 |
10:12 ET | 70075 | 65.25 |
10:14 ET | 50668 | 65.29 |
10:15 ET | 21092 | 65.38 |
10:17 ET | 12585 | 65.305 |
10:19 ET | 27290 | 65.25 |
10:21 ET | 24865 | 65.2422 |
10:24 ET | 24362 | 65.22 |
10:26 ET | 13759 | 65.22 |
10:28 ET | 21396 | 65.32 |
10:30 ET | 22010 | 65.24 |
10:32 ET | 12150 | 65.24 |
10:33 ET | 23138 | 65.13 |
10:35 ET | 11946 | 65.1 |
10:37 ET | 19521 | 65.14 |
10:39 ET | 24405 | 65.15 |
10:42 ET | 16928 | 65.21 |
10:44 ET | 24547 | 65.12 |
10:46 ET | 37884 | 64.98 |
10:48 ET | 13116 | 64.92 |
10:50 ET | 28614 | 64.95 |
10:51 ET | 31781 | 64.96 |
10:53 ET | 26519 | 64.96 |
10:55 ET | 43714 | 64.85 |
10:57 ET | 25805 | 64.81 |
11:00 ET | 25591 | 64.815 |
11:02 ET | 30512 | 64.805 |
11:04 ET | 25992 | 64.75 |
11:06 ET | 29309 | 64.71 |
11:08 ET | 27612 | 64.74 |
11:09 ET | 33760 | 64.76 |
11:11 ET | 20639 | 64.74 |
11:13 ET | 33888 | 64.755 |
11:15 ET | 22332 | 64.78 |
11:18 ET | 30371 | 64.86 |
11:20 ET | 24682 | 64.77 |
11:22 ET | 17740 | 64.72 |
11:24 ET | 22258 | 64.75 |
11:26 ET | 22259 | 64.685 |
11:27 ET | 19193 | 64.705 |
11:29 ET | 32023 | 64.73 |
11:31 ET | 50607 | 64.73 |
11:33 ET | 61067 | 64.905 |
11:36 ET | 47549 | 64.94 |
11:38 ET | 8867 | 64.82 |
11:40 ET | 3773 | 64.78 |
11:42 ET | 15629 | 64.9 |
11:44 ET | 2637 | 64.9406 |
11:45 ET | 6810 | 64.96 |
11:47 ET | 9587 | 64.99 |
11:49 ET | 21219 | 64.93 |
11:51 ET | 21382 | 64.86 |
11:54 ET | 24043 | 64.89 |
11:56 ET | 9953 | 64.91 |
11:58 ET | 15829 | 64.86 |
12:00 ET | 11557 | 64.8 |
12:02 ET | 13574 | 64.81 |
12:03 ET | 15531 | 64.66 |
12:05 ET | 22112 | 64.63 |
12:07 ET | 18194 | 64.665 |
12:09 ET | 18555 | 64.68 |
12:12 ET | 10205 | 64.68 |
12:14 ET | 8211 | 64.59 |
12:16 ET | 12582 | 64.6 |
12:18 ET | 9808 | 64.63 |
12:20 ET | 5643 | 64.66 |
12:21 ET | 9447 | 64.62 |
12:23 ET | 5132 | 64.76 |
12:25 ET | 6744 | 64.8 |
12:27 ET | 4333 | 64.85 |
12:30 ET | 9324 | 64.79 |
12:32 ET | 8317 | 64.83 |
12:34 ET | 7129 | 64.8 |
12:36 ET | 5109 | 64.85 |
12:38 ET | 6396 | 64.86 |
12:39 ET | 18315 | 64.91 |
12:41 ET | 10868 | 64.9061 |
12:43 ET | 6440 | 64.8 |
12:45 ET | 1800 | 64.815 |
12:48 ET | 7668 | 64.75 |
12:50 ET | 6177 | 64.7 |
12:52 ET | 6659 | 64.69 |
12:54 ET | 10397 | 64.7 |
12:56 ET | 8469 | 64.69 |
12:57 ET | 4694 | 64.71 |
12:59 ET | 3826 | 64.695 |
01:01 ET | 6183 | 64.725 |
01:03 ET | 6345 | 64.75 |
01:06 ET | 9826 | 64.72 |
01:08 ET | 5490 | 64.69 |
01:10 ET | 5000 | 64.72 |
01:12 ET | 8915 | 64.72 |
01:14 ET | 4438 | 64.73 |
01:15 ET | 5179 | 64.73 |
01:17 ET | 9401 | 64.76 |
01:19 ET | 7571 | 64.835 |
01:21 ET | 9643 | 64.81 |
01:24 ET | 9360 | 64.8326 |
01:26 ET | 22702 | 64.815 |
01:28 ET | 7476 | 64.8 |
01:30 ET | 13028 | 64.76 |
01:32 ET | 8563 | 64.735 |
01:33 ET | 5977 | 64.74 |
01:35 ET | 6842 | 64.75 |
01:37 ET | 14895 | 64.82 |
01:39 ET | 4465 | 64.81 |
01:42 ET | 10449 | 64.82 |
01:44 ET | 13211 | 64.825 |
01:46 ET | 7743 | 64.81 |
01:48 ET | 6351 | 64.775 |
01:50 ET | 11533 | 64.805 |
01:51 ET | 13857 | 64.805 |
01:53 ET | 39362 | 64.755 |
01:55 ET | 6389 | 64.73 |
01:57 ET | 7450 | 64.74 |
02:00 ET | 5944 | 64.73 |
02:02 ET | 19013 | 64.72 |
02:04 ET | 47417 | 64.82 |
02:06 ET | 17076 | 64.79 |
02:08 ET | 20347 | 64.79 |
02:09 ET | 13041 | 64.81 |
02:11 ET | 15151 | 64.835 |
02:13 ET | 4788 | 64.845 |
02:15 ET | 15731 | 64.86 |
02:18 ET | 6205 | 64.86 |
02:20 ET | 16843 | 64.88 |
02:22 ET | 6882 | 64.865 |
02:24 ET | 11367 | 64.9002 |
02:26 ET | 11080 | 64.92 |
02:27 ET | 12217 | 64.95 |
02:29 ET | 20870 | 64.96 |
02:31 ET | 36463 | 65 |
02:33 ET | 27305 | 65.0416 |
02:36 ET | 7262 | 65.1 |
02:38 ET | 17671 | 65.15 |
02:40 ET | 41559 | 65.125 |
02:42 ET | 15720 | 65.15 |
02:44 ET | 8259 | 65.16 |
02:45 ET | 19094 | 65.15 |
02:47 ET | 14790 | 65.16 |
02:49 ET | 5650 | 65.16 |
02:51 ET | 15816 | 65.18 |
02:54 ET | 15053 | 65.185 |
02:56 ET | 7025 | 65.185 |
02:58 ET | 10346 | 65.25 |
03:00 ET | 9369 | 65.23 |
03:02 ET | 9629 | 65.17 |
03:03 ET | 6979 | 65.21 |
03:05 ET | 26548 | 65.2606 |
03:07 ET | 13723 | 65.29 |
03:09 ET | 43000 | 65.27 |
03:12 ET | 13426 | 65.285 |
03:14 ET | 25697 | 65.32 |
03:16 ET | 16420 | 65.335 |
03:18 ET | 34808 | 65.285 |
03:20 ET | 29606 | 65.24 |
03:21 ET | 16166 | 65.34 |
03:23 ET | 22918 | 65.4 |
03:25 ET | 22949 | 65.44 |
03:27 ET | 24247 | 65.41 |
03:30 ET | 28087 | 65.435 |
03:32 ET | 18487 | 65.36 |
03:34 ET | 18518 | 65.4 |
03:36 ET | 11209 | 65.405 |
03:38 ET | 26425 | 65.35 |
03:39 ET | 23011 | 65.355 |
03:41 ET | 33757 | 65.34 |
03:43 ET | 50934 | 65.385 |
03:45 ET | 42558 | 65.35 |
03:48 ET | 38338 | 65.395 |
03:50 ET | 51392 | 65.42 |
03:52 ET | 72503 | 65.435 |
03:54 ET | 45063 | 65.42 |
03:56 ET | 104985 | 65.46 |
03:57 ET | 136289 | 65.5 |
03:59 ET | 413238 | 65.51 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
AstraZeneca PLC | 202.5B | -197.4x | -50.95% |
Novartis AG | 204.6B | 7.9x | +30.61% |
Bristol-Myers Squibb Co | 163.6B | 27.0x | +3.27% |
Merck & Co Inc | 233.7B | 16.9x | +28.17% |
Sanofi SA | 129.7B | 18.2x | +7.84% |
Amgen Inc | 131.2B | 24.3x | +0.08% |
AstraZeneca PLC is a patient-focused pharmaceutical company. The Company focuses on discovery and development, manufacturing and commercialization of prescription medicines. The Company is focused on various therapy areas, such as Oncology; BioPharmaceuticals (comprising Cardiovascular, Renal & Metabolism (CVRM) and Respiratory & Immunology (R&I)), and Rare Disease. Its pipeline forms a robust portfolio of investigational therapies in various stages of clinical development. Its pipeline includes the Alexion Rare Disease portfolio and comprises approximately 177 projects, of which 161 are in the clinical phase of development. Its key marketed oncology products include Tagrisso (osimertinib), Lynparza (olaparib), Imfinzi (durvalumab), Koselugo (selumetinib), Farxiga/ Forxiga (dapagliflozin), Roxadustat, Onglyza (saxagliptin) and others. The Company’s geographical segments include United Kingdom, Rest of Europe, The Americas and Asia, Africa & Australasia.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $202.6B |
---|---|
Revenue (TTM) | $41.5B |
Shares Outstanding | 3.1B |
Dividend Yield | 3.64% |
Annual Dividend Rate | 2.3850 USD |
Ex-Dividend Date | 02-24-22 |
Pay Date | 03-28-22 |
Beta | 0.46 |
EPS | $-0.33 |
Book Value | $12.67 |
P/E Ratio | -197.4x |
Price/Sales (TTM) | 4.9 |
Price/Cash Flow (TTM) | 33.9x |
Operating Margin | 0.09% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.